Related Experiment Video
Updated: Feb 2, 2026

Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
Exosomes from mesenchymal stem cells expressing miR-125b inhibit neointimal hyperplasia via myosin IE
Dongqing Wang1,2, Bin Gao3, Jianing Yue1
1Department of Vascular Surgery, Zhongshan Hospital Fudan University, Shanghai, China.
Abstract:
Intercellular communication between mesenchymal stem cells (MSCs) and their target cells in the perivascular environment is modulated by exosomes derived from MSCs. However, the potential role of exosome-mediated microRNA transfer in neointimal hyperplasia remains to be investigated. To evaluate the effects of MSC-derived exosomes (MSC-Exo) on neointimal hyperplasia, their effects upon vascular smooth muscle cell (VSMC) growth in vitro and neointimal hyperplasia in vivo were assessed in a model of balloon-induced vascular injury. Our results showed that MSC-Exo were internalised by VSMCs and inhibited proliferation and migration in vitro. Further analysis revealed that miR-125b was enriched in MSC-Exo, and repressed the expression of myosin 1E (Myo1e) by targeting its 3' untranslated region. Additionally, MSC-Exo and exosomally transferred miR-125b repressed Myo1e expression and suppressed VSMC proliferation and migration and neointimal hyperplasia in vivo. In summary, our findings revealed that MSC-Exo can transfer miR-125b to VSMCs and inhibit VSMC proliferation and migration in vitro and neointimal hyperplasia in vivo by repressing Myo1e, indicating that miR-125b may be a therapeutic target in the treatment of vascular diseases.
Insights
Mesenchymal stem cell-derived exosomes (MSC-Exo) inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. MSC-Exo transfer miR-125b, which represses Myo1e, offering a potential therapeutic strategy for vascular diseases.
Area of Science:
- Regenerative Medicine
- Vascular Biology
- Cellular and Molecular Biology
Background:
- Mesenchymal stem cells (MSCs) communicate with target cells via exosomes, influencing the perivascular environment.
- The role of exosome-mediated microRNA transfer in neointimal hyperplasia is not well understood.
Purpose of the Study:
- To investigate the effects of MSC-derived exosomes (MSC-Exo) on neointimal hyperplasia.
- To elucidate the underlying molecular mechanisms, including microRNA transfer and target gene regulation.
Main Methods:
- Assessed MSC-Exo effects on vascular smooth muscle cell (VSMC) proliferation and migration in vitro.
- Utilized a balloon-induced vascular injury model in vivo to evaluate neointimal hyperplasia.
- Identified and quantified microRNAs within MSC-Exo, focusing on miR-125b and its target gene, myosin 1E (Myo1e).
Main Results:
- MSC-Exo were internalized by VSMCs, inhibiting their proliferation and migration in vitro.
- miR-125b was found to be enriched in MSC-Exo and targeted the 3' untranslated region of Myo1e, repressing its expression.
- MSC-Exo and transferred miR-125b suppressed Myo1e expression, VSMC proliferation, migration, and neointimal hyperplasia in vivo.
Conclusions:
- MSC-Exo inhibit VSMC proliferation and neointimal hyperplasia by transferring miR-125b.
- The miR-125b/Myo1e axis plays a critical role in regulating neointimal hyperplasia.
- MSC-Exo and miR-125b represent potential therapeutic targets for vascular diseases.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
The Role of Actin and Myosin in Non-muscle Cells
Feedback Inhibition
Induced Pluripotent Stem Cells
Adult Stem Cells

